EBITDA

Hunt Energy Network acquires the massive Fort Duncan battery, boosting its Texas portfolio to 420MW and signaling an aggressive expansion in the booming ERCOT market.

Facing SEC delays, Aptose Biosciences secures an $11.1M lifeline from its acquirer, Hanmi, highlighting financial strain as the critical deal moves forward.

The partnership moves beyond compliance, integrating deep binary analysis with lifecycle management to provide continuous software risk intelligence for critical industries.

Cell and gene therapy manufacturer OXB posts a dramatic turnaround to profitability, with surging revenues and an ambitious forecast for the coming years.

With its Moda-flx system cleared by the FDA, Diality hires M&A expert Peter Donato to navigate the path to commercialization in the $92B dialysis market.

A new report shows patients are rejecting 'overdone' looks for subtle, strategic care, driven by Ozempic, menopause, and a desire for authenticity.

Fintech firm Chronograph hires a private credit expert from Blue Owl and partners with AI leader Anthropic to revolutionize portfolio monitoring.

Planet Fitness reports a 12.1% revenue surge and adds 1.1 million members, proving its model's resilience even as Wall Street weighs future growth.

After a massive divestiture, Brightstar Lottery slashes debt, rewards investors, and sets its sights on digital expansion in Italy and Brazil.

SLC Digital and Tracer Labs partner to combat rampant account takeover fraud, combining hardware-rooted security with a privacy-first digital identity.

Riding a wave of 41% Q4 revenue growth and nearing profitability, the diagnostics firm will showcase its lung cancer solutions at two major conferences.

After a challenging year, iGaming affiliate Gentoo Media posts record Q4 profits, signaling a successful pivot to a leaner model ahead of a key refinancing.

With a record $1.2B order backlog and a bullish 2026 forecast, the specialty vehicle maker also announces a major leadership shift to drive its next growth phase.

Following major design awards, South Korean kids' brand oddBi expands to the UAE, tapping into a booming luxury market with its customizable backpacks.

Avacta's pre|CISION therapy shows faster, more potent, and more selective tumor targeting than Enhertu in an AI-driven study, paving the way for 2026 trials.

The coffee giant posts impressive 2025 results amid high inflation, paving the way for its blockbuster acquisition by Keurig Dr Pepper. What's next?

A new partnership brings an FDA-designated breakthrough device to more patients, fueled by a key Medicare payment that could reshape the trauma market.

The cannabis giant upsizes its credit facility by CAD $15M, signaling strong lender confidence and fueling its ambitious global expansion plans.

The hospitality REIT posts a record year, fueled by strong group bookings at its Gaylord hotels and an aggressive expansion into live entertainment markets.

Beam Therapeutics is set to announce its 2025 financial results and a new liver-targeted therapy, a key moment for its base editing platform and investors.